Skip to main content
. Author manuscript; available in PMC: 2014 Dec 15.
Published in final edited form as: JAMA. 2014 Jun 18;311(23):2387–2396. doi: 10.1001/jama.2014.5616

Figure 1.

Figure 1

Study flow

1Participants who did not receive the allocated intervention, i.e. attended no intervention sessions.

2For participants who did not have any MMD assessments, we assigned one hour of follow-up time, since we knew that they were able to do the 400m walk at baseline.

3Partial follow-up indicates participants who had censoring times prior to the last planned follow-up visit.

4Discontinuation of the intervention was operationalized as participants who did not attend at least one intervention session during their last 6-months of follow-up prior to the last planned follow-up visit date. Deaths and intervention withdrawals are included in these numbers. As an example, a participant may have discontinued the intervention in the initial six month of follow-up due to illness and then died prior to the 6-months assessment for the primary outcome. This participant would be reflected as missing the primary outcome due to death and also discontinuing the intervention.